Related Experiment Videos
Premature atherosclerosis in systemic lupus erythematosus
Mandana Nikpour1, Murray B Urowitz, Dafna D Gladman
1University of Toronto Lupus Clinic, Toronto Western Hospital, ON M5T 2S8, Canada.
Rheumatic Diseases Clinics of North America
|June 1, 2005
Summary
Systemic lupus erythematosus (SLE) patients now have improved survival rates due to better treatments. However, they face a high risk of premature coronary artery disease (CAD), necessitating new screening and management strategies.
Area of Science:
- Rheumatology
- Cardiology
- Immunology
Background:
- Systemic lupus erythematosus (SLE) prognosis has dramatically improved, with 5-year survival rates increasing from <50% to 93%.
- Despite improved short-term survival, long-term survivors of SLE often develop premature coronary artery disease (CAD).
Purpose of the Study:
- To define the extent of premature atherosclerosis in SLE patients.
- To evaluate the strength of associated risk factors for CAD in SLE.
- To explore noninvasive assessment methods and propose a screening/management strategy for CAD in SLE.
Main Methods:
- Evidence-based review of existing literature.
- Analysis of risk factors for premature CAD in SLE.
- Focus on emerging noninvasive vascular health assessment modalities.
Main Results:
- SLE patients face a significant burden of premature atherosclerosis and CAD.
- Established and emerging risk factors contribute to accelerated CAD development in SLE.
- Noninvasive vascular assessment tools show promise for early detection.
Conclusions:
- Improved SLE management has shifted focus to long-term complications like premature CAD.
- A proactive screening and management strategy is crucial for SLE patients at risk of CAD.
- Further research is needed to address remaining questions and refine CAD management in SLE.